Health score, competitive moat, risk signals, and key metrics at a glance.
Competitive analysis based on 62 quarters of fundamental data
Operating margins are under pressure, averaging 4.7%. The business may lack pricing power or face rising costs.'
ROE is positive at ~2.1% on average, adequate but below the threshold typically associated with wide moats.
Data-driven red flags and warnings across 62 quarters
The company posted negative operating margins in recent quarters — core operations are unprofitable.
FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.
Debt-to-equity has risen 24.7% recently — increasing financial risk even if the current ratio is manageable.
Revenue is stable or growing over recent quarters — demand appears durable.
Free cash flow is consistently positive — the business self-funds without external capital reliance.
Shares decreased 2.5% — net buybacks are reducing shares outstanding and boosting per-share value.
as of September 2025
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
Free cash flow is consistently positive and growing — a hallmark of a capital-light business that can self-fund growth.
Revenue shows resilience with 4 of 7 quarters posting growth — demand is generally stable but has seen some soft patches.
